Status:
WITHDRAWN
Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)
Lead Sponsor:
Abbott RDx Cardiometabolic
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
21+ years
Phase:
PHASE4
Brief Summary
This clinical trial is being conducted to 1) evaluate the possible usefulness of a panel of cardiac markers in assessing emergency department patients with possible acute coronary syndrome, 2) evaluat...
Detailed Description
The correct diagnosis of acute coronary syndrome (ACS) remains a frequent significant challenge for emergency physicians. Over eight million chest pain patients present annually and despite promising ...
Eligibility Criteria
Inclusion
- Age greater than or equal to 21 years at the time of enrollment Chest discomfort or other symptoms consistent with possible ACS as indicated by the treating physician obtaining an ECG and cardiac markers for the patient's evaluation New onset or worsening symptoms within six hours of presentation to the ED.
Exclusion
- History of CHF per patient history or in the available medical record. History of end stage renal disease on dialysis. Refused informed consent.4) Refused medical record review and telephone follow up at 30 days and six months.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00206817
Start Date
October 1 2003
Last Update
July 21 2015
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Medical Center
Sacramento, California, United States, 95817
2
Henry Ford Health Systems
Detroit, Michigan, United States, 48202
3
Carolinas Medical Center
Charlotte, North Carolina, United States, 28203
4
Wake Forest Univ. Baptist Med. Center
Winston-Salem, North Carolina, United States, 27157